In this episode of Big Deal, CNBC-TV18’s Nisha Poddar is in conversation with Shweta Jalan, MD & Head at Advent India, VL Rajesh, Operating Partner at Advent India and Bhasker Iyer, Operating Partner at Advent India. The top team at Advent India to talked about their strategy and views on investing in India.
Shweta Jalan said, “Beginning of year felt like it is going to be very tough, but on balance if I look at my portfolio, I actually feel better about it than I did about six months back. Each one of the companies have come far stronger and far better than they were at the beginning of this year. The focus on liquidity, cash, cost controls, working capital all of which we do under the normal circumstances as well, I think all are management teams double clicked on those and at this point in time each of those metrics they have really brought continuous and significant improvement.”
On acquisitions, Bhasker Iyer said, “We acquired RA Chem Pharma very recently. Our plan in the absolute short term is to strengthen operations and intensely drive cost reduction initiatives. If the cost leadership that we achieve which will help us penetrate new customers, new markets and also grow our market share.”
“We have a clearly defined acquisition strategy, the plan is to acquire a few companies in the next 12-18 months, get the business to a respectable scale and then focus on growing it organically by driving robust double-digit growth."Watch this video for more.